Overview

• A June 10 study in Environmental Health found dose-related rises in malignant and benign tumors among rats exposed to glyphosate at levels the EU considers non-hazardous.
• On June 12 several environmental groups including PAN Europe and Générations Futures urged European institutions to revoke glyphosate’s authorization, arguing it fails to meet safety requirements.
• Researchers led by Daniele Mandrioli tested hundreds of rats and noted results consistent with epidemiological data tying human glyphosate exposure to cancer.
• The IARC classifies glyphosate as a probable carcinogen, yet EU agencies maintain the substance poses no critical risk and extended its approval through 2033.
• Bayer, facing mounting litigation over Roundup, has cast doubt on glyphosate’s commercial future as France bans its domestic sale but allows controlled agricultural use.